ArticleArchives of internal medicine1975
IgD multiple myeloma. Review of 133 cases.
Article in Archives of internal medicine, 1975. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed, 183 citations in OpenAlex.
- Immunoglobulin D-Lambda Multiple Myeloma Initially Presenting in the Sphenoid Sinus, Orbital Apex, and Skull Base: A Systematic Review with a Case Report.Journal of neurological surgery reports · 2024Article
- [Analysis of efficacy and safety of BCMA chimeric antigen receptor T cells in the treatment of 5 patients with recurrent/refractory IgD multiple myeloma].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2023Article
- Amyloidosis: a case series and review of the literature.Journal of medical case reports · 2023Review
- Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials.Blood advances · 2022Article
- Immunoglobulin D Multiple Myeloma: A Rare Variant.Cureus · 2022Article
- Plasma exchange combined with bortezomib-based chemotherapy is effective for early renal recovery in a patient with IgD-λ type multiple myeloma.CEN case reports · 2020Article
- Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experience.Cancer communications (London, England) · 2019Article
- "D" is for Dilemma.Cureus · 2019Article
- N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma.BMC cancer · 2017Article
- Acute kidney injury in cancer patients and impedance cardiography-assisted renal replacement therapy: Experience from the onconephrology unit of a Chinese tertiary hospital.Experimental and therapeutic medicine · 2017Article
- Muscle Hypertrophy in a Patient with Immunoglobulin D Multiple Myeloma.Journal of general internal medicine · 2016Article
- Old but Still Relevant: High Resolution Electrophoresis and Immunofixation in Multiple Myeloma.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2016Review
- Multiple myeloma with intracranial extension and bilateral renal infiltration: A case report and review of the literature.Oncology letters · 2015Article
- IgD heavy-chain deposition disease: detection by laser microdissection and mass spectrometry.Journal of the American Society of Nephrology : JASN · 2015Article
- Aggressive FLC Escape in a Patient with IgD Myeloma.Case reports in hematology · 2015Article
- Solitary spinal extradural plasmacytoma: a case report and literature review.Clinical neuroradiology · 2013Review
- IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy.Journal of experimental & clinical cancer research : CR · 2012Article
- Extramedullary plasmacytoma in the presence of multiple myeloma: clinical correlates and prognostic relevance.OncoTargets and therapy · 2012Article
- Myelomatous pleural effusion: a case series in a single institution and literature review.The Korean journal of laboratory medicine · 2011Review
- Efficacy and outcome of autologous transplantation in rare myelomas.Haematologica · 2010Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One hundred thirty-three patients had IgD myeloma. The IgD comprises 0.8% of M-components in general and 2.1% of myelomas in particular. Males predominate and 65% of the patients are younger than 60 years at the diagnosis. More than half of the patients have lymphadenopathy, hepatomegaly, or splenomegaly. Extraosseous spread and amyloidosis are frequent. Severe anemia and azotemia are common. Total serum protein and IgD M-component levels are usually not high. LAMBDA-type light chains are found in 90% of IgD M-components. Bence Jones proteinimia is frequent and Bence Jones proteinuria appears in almost all patients. Mean survival is 13.7 months from diagnosis. The IgD is different from IgG and IgA myeloma, indicating that the clinical picture and course of multiple cyeloma may be related to the class and type of M-component.
Indexed as
Identifiers
1111472W2001077299What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.